SearchThe Clinical Research Department at NKI is committed to advancing the treatment of severe psychiatric disorders, including schizophrenia, depression, and bipolar disorder, by pursuing clinical trials with novel pharmacological and neuromodulation strategies.
In collaboration with other NKI departments we also conduct a range of research experiments that aim to increase our understanding of the structural, biochemical, and functional brain abnormalities in severe psychiatric disorders, an understanding which will hopefully lead to better diagnosis and treatment for our patients.
